At Materialize Bio, we're pushing the boundaries of MedTech by developing advanced biopolymer-based implants. We believe in creating solutions that are safer, more natural, and better for the body than traditional metal and plastic.
Materialize Bio is a Tufts-spin out with disruptive and highly scalable 3D manufacturing methods tailored specifically for biopolymers. Materialize's platform taps into the exceptional regenerative, antimicrobial and material properties of natural biopolymers, which are wildly underutilized as medical implants because of difficulties in fast, cost-effective prototyping and efficient production.
With a range of concepts, their first focus is bringing breakthrough biopolymer ear tubes to market, with novel features and drug-elution capabilities. They are uniquely positioned to enhance the quality of healthcare with their functionalized implants, marking a pivotal moment as biopolymer technology finally makes its dent in both high-volume and personalized implant markets.
Company Details
- Employees
- 4
- Founded
- -
- Address
- Those Risks Head-On.
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.materializebio.com
- Keywords
- IT Consulting.
Materialize Bio Questions
Materialize Bio's website is http://www.materializebio.com
Materialize Bio's LinkedIn profile is https://www.linkedin.com/company/materialize-bio
Materialize Bio has
4 employees.
View email and phone details for 4
employees at Materialize Bio.
Materialize Bio's industry is
Biotechnology Research
Materialize Bio's top competitors are
Kofimi Technology, Inc.,
Pathcision Medicine,
Betty Health,
Wiseai,
Reconstruct Bio,
Limax Biosciences,
Barlume Cosmetics,
Craniosense,
Manglovo Health,
Brixton Biosciences.
Materialize Bio's categories are Biotechnology Research
Materialize Bio's founding year is 2023
